Published in Vaccine Weekly, May 27th, 1996
Because it has been shown that T-cell destruction of human melanomas will not occur if the melanoma tumor lacks the necessary co-stimulatory molecule, lacks sufficient MHC expression, and lacks the necessary melanoma tumor antigen, Mark. R. Albertini et al. explored the possibility of dual transfection of melanoma cells to facilitate T-cell destruction and presented the results at the 87th Annual Meeting of the American Association for Cancer Research, held April 20-24, 1996, in Washington, DC.
"The importance of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.